V.P. Stus
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
Papers in
-
- Renal cell carcinoma treatment 19
-
- Renal and related cancers 11
- Co-authors
- Brad Rosbrook (4 shared papers)Nicholas J. Vogelzang (3 shared papers)Thomas E. Hutson (4 shared papers)С Х Аль-Шукри (4 shared papers)Elizabeth R. Plimack (10 shared papers)Bohuslav Melichar (8 shared papers)Dmitry Nosov (10 shared papers)Brian I. Rini (10 shared papers)
- Journals
- Journal of Clinical Oncology (11 papers)The Lancet Oncology (3 papers)Clinical Infectious Diseases (2 papers)Open Forum Infectious Diseases (2 papers)European Urology (1 paper)
- Partner nations
- United StatesUkraineRussia
In The Last Decade
V.P. Stus
28 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 84
- Applied Microbiology and Biotechnology 137
- Molecular Medicine 318
- Pulmonary and Respiratory Medicine 1.1k
- Cancer Research 441
- Oncology 638
Countries citing papers authored by V.P. Stus
This map shows the geographic impact of V.P. Stus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V.P. Stus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V.P. Stus more than expected).
Fields of papers citing papers by V.P. Stus
This network shows the impact of papers produced by V.P. Stus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V.P. Stus. The network helps show where V.P. Stus may publish in the future.
Co-authors
The 25 scholars most cited alongside V.P. Stus, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pembrolizumab plus axitinib versus sunitinib monotherapy as first-line treatment of advanced renal cell carcinoma (KEYNOTE-426): extended follow-up from a randomised, open-label, phase 3 trial Hit paper breakdown → | 2020 | 498 |
| 2 | 2013 | 320 | |
| 3 | RESTORE-IMI 1: A Multicenter, Randomized, Double-blind Trial Comparing Efficacy and Safety of Imipenem/Relebactam vs Colistin Plus Imipenem in Patients With Imipenem-nonsusceptible Bacterial Infections Hit paper breakdown → | 2019 | 284 |
| 4 | 2019 | 100 | |
| 5 | 2019 | 86 | |
| 6 | 2021 | 75 | |
| 7 | 2023 | 73 | |
| 8 | 2016 | 49 | |
| 9 | 2020 | 46 | |
| 10 | 2023 | 45 | |
| 11 | 2013 | 27 | |
| 12 | 2017 | 13 | |
| 13 | 2019 | 11 | |
| 14 | 2024 | 8 | |
| 15 | 2021 | 8 | |
| 16 | The role of lead in the etiopathogenesis of male fertility reduction. | 2019 | 6 |
| 17 | 2021 | 5 | |
| 18 | 2022 | 4 | |
| 19 | 2024 | 4 | |
| 20 | 2019 | 3 |
About V.P. Stus
V.P. Stus is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Epidemiology, Oncology and Surgery, having authored 47 papers that have together received 1.7k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (19 papers), Renal and related cancers (11 papers), Cancer Immunotherapy and Biomarkers (8 papers), Urinary Tract Infections Management (7 papers), Cancer Genomics and Diagnostics (7 papers), Economic and Financial Impacts of Cancer (5 papers), Urinary Bladder and Prostate Research (5 papers) and Bladder and Urothelial Cancer Treatments (5 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (137 citations), Molecular Medicine (318 citations), Pulmonary and Respiratory Medicine (1.1k citations), Cancer Research (441 citations) and Oncology (638 citations). V.P. Stus has collaborated with scholars based in United States, Ukraine and Russia. Frequent co-authors include Brad Rosbrook, Nicholas J. Vogelzang, Thomas E. Hutson, С Х Аль-Шукри, Elizabeth R. Plimack, Bohuslav Melichar, Dmitry Nosov, Brian I. Rini, Delphine Borchiellini and Denis Soulières. Their work appears in journals such as Journal of Clinical Oncology, The Lancet Oncology, Clinical Infectious Diseases, Open Forum Infectious Diseases and European Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.